^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

zedenoleucel (MT-401)

i
Other names: MT-401, multi-antigen targeted autologous cytotoxic T cell therapy for AML, MultiTAA T cell therapy for AML
Associations
Trials
Company:
Marker Therap
Drug class:
T lymphocyte replacement
Associations
Trials